COMMUNIQUÉS West-GlobeNewswire

Immuron CEO Dr. Gary S. Jacob to Present at the ThinkEquity Conference on May 2, 2019

30/04/2019 - 20:36

MELBOURNE, Australia, April 30, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immuno-therapeutics for the [...]

Adverum Biotechnologies Presents First Preclinical Data on Dosing Contralateral Eye with ADVM-022 Gene Therapy for Wet AMD at the ARVO 2019 Annual Meeting

30/04/2019 - 19:30

-- ADVM-022 Safely Administered Sequentially to the Second Eye in Preclinical Study -- MENLO PARK, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy [...]

Corporate Governance Report and Non-financial Statement of 2018

30/04/2019 - 18:57

“Grindeks” audited consolidated financial statements of 2018 is submitted to “Nasdaq Riga” together with Corporate Governance Report and Non-financial Statement of the year of 2018. Further information: Laila Klavina [...]

On “Grindeks” audited results in 2018

30/04/2019 - 18:49

Today, on 30 April, the JSC “Grindeks” submitted the audited consolidated financial statements of 2018 to “Nasdaq Riga”. Audited financial results indicate that the Group’s turnover in 2018 was 145.5 million euro and [...]

Immucor Announces Health Canada Approval for NEO Iris™; Next Generation, Fully Automated Instrument for Transfusion Medicine

30/04/2019 - 18:21

Highest throughput for immunohematology now powered with clearer results for brilliant performance NORCROSS, Ga., April 30, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation [...]

AB Science reports today its annual financials as of 31 December 2018 and provides an update on its activities

30/04/2019 - 18:16

Paris, April 30, 2019 – 6pm Net loss of 26.1M€ for the year 2018 Cash position of 11.6M€ as of 31 December 2018, plus 5.7M€ of 2018 tax credit AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company [...]

AB Science annonce aujourd’hui ses résultats financiers annuels arrêtés au 31 décembre 2018 et présente l’actualité de ses activités

30/04/2019 - 18:16

Paris, le 30 avril 2019 – 18h Perte nette de 26,1M€ pour l’année 2018 Trésorerie de 11,6M€ au 31 décembre 2018, à laquelle s’ajoutent 5,7M€ de crédit d’impôt 2018 AB Science SA (NYSE Euronext - FR0010557264 - AB), [...]

Sanofi: Annual General Meeting of April 30, 2019

30/04/2019 - 18:01

Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Annual General Meeting of April 30, 2019 Approval of the financial statements for the fiscal year 2018 Dividend of €3.07 per share payable as of May 13, 2019 [...]

Sanofi : Assemblée Générale Annuelle du 30 avril 2019

30/04/2019 - 18:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Assemblée Générale Annuelle du 30 avril 2019 Approbation des comptes sociaux et des comptes consolidés de l'exercice 2019 Dividende de 3,07 euros par [...]

Homology Medicines Presents Data Demonstrating Suite of Novel AAV Vectors Targeted Key Cell Types for Inherited Retinal Diseases

30/04/2019 - 18:00

Presentation Highlights Targeted Biodistribution in Multiple Models following Different Routes of Administration BEDFORD, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic [...]

Kiadis Pharma announces annual results for the year ended December 31, 2018

30/04/2019 - 17:46

Amsterdam, The Netherlands, 30 April 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical-stage biopharmaceutical company, today announces its audited 2018 [...]

Néovacs : mise à disposition du rapport financier annuel 2018 et du rapport sur le gouvernement d'entreprise

30/04/2019 - 17:45

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018 ET DU RAPPORT SUR LE GOUVERNEMENT D'ENTREPRISE Paris et Boston, le 30 avril 2019 - 17h45 CEST – [...]

Allscripts Sunrise™ goes live in Gippsland

30/04/2019 - 17:22

First in Australia to incorporate Microsoft’s Azure cloud platform CHICAGO, April 30, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) has expanded its footprint in Australia with a successful go-live at Latrobe [...]

Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2019

30/04/2019 - 17:19

Bagsværd, Denmark, 30 April 2019 - In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo [...]

EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer

30/04/2019 - 17:17

New Study Finds Many Women May Receive Unnecessary Chemotherapy Treatment SALT LAKE CITY, April 30, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today [...]

JSC Olainfarm ESG Report for the Year 2018.

30/04/2019 - 17:00

JSC Olainfarm hereby publishes the ESG Report for the Year 2018. Additional information: Dana Hasana Head of PR dana.hasana@olainfarm.com Ph. +371 26355895 Attachment Olainfarm_ESG_Zinojums_ENG_2019

Axiom Real-Time Metrics Exhibiting at Clinical Operations in Oncology Trials West Coast 2019

30/04/2019 - 17:00

TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 30 th and May 1 st [...]

Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019

30/04/2019 - 16:45

EAST RUTHERFORD, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]

JSC Olainfarm Consolidated and Parent Company's Annual Report for Year 2018

30/04/2019 - 16:12

Olainfarm’s revenues continue to increase; EBITDA margin improves Audited consolidated revenues of JSC Olainfarm for 2018 exceeded 124 million euros. This represents an increase by 2% compared to sales of 2017 and is [...]